Kyoto University Succeeds In Producing Thrombocytopenia With iPS Cells
This article was originally published in PharmAsia News
Executive Summary
Kyoto University research groups have succeeded in regenerating the pathology of congenital amegakaryocytic thrombocytopenia using iPS cells from patients with CAMT disease.